Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Epigenetics|July 6, 2023
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needsKatleen Janssens, Isabelle Neefs, Joe Ibrahim, et al.
Bone|May 11, 2020
A multi-omics approach expands the mutational spectrum of MAP2K1-related melorheostosisRaphaël De Ridder, Eveline Boudin, M Carola Zillikens, et al.
Cancer Medicine|April 18, 2019
Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancerJoe Ibrahim, Ken Op de Beeck, Erik Fransen, et al.
Clinical Epigenetics|April 24, 2018
Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancerLieselot Croes, Matthias Beyens, Erik Fransen, et al.
Cancers|June 10, 2020
PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different PrognosisGitta Boons, Timon Vandamme, Joe Ibrahim, et al.
British Journal of Cancer|August 24, 2024
IMPRESS: Improved methylation profiling using restriction enzymes and smMIP sequencing, combined with a new biomarker panel, creating a multi-cancer detection assayJanah Vandenhoeck, Isabelle Neefs, Thomas Vanpoucke, et al.
Clinical Epigenetics|December 3, 2024
Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseasesJanah Vandenhoeck, Joe Ibrahim, Nele De Meulenaere, et al.
International Journal of Molecular Sciences|November 25, 2023
Mitochondrial GpC and CpG DNA Hypermethylation Cause Metabolic Stress-Induced Mitophagy and CholestophagyClaudia Theys, Joe Ibrahim, Ligia Mateiu, et al.
Frontiers in Molecular Medicine|August 1, 2024
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)Claudia Theys, Tineke Vanderhaeghen, Evelien Van Dijck, et al.
Molecular Oncology|November 14, 2025
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologiesJanah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, et al.
Pageof 3